---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-005036"
form_type: "8-K"
ticker: "CDT"
cik: "0001896212"
company_name: "CDT Equity Inc."
filed_at: "2025-04-16T23:59:59+00:00"
generated_at: "2026-05-23T13:53:40.176606+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Conduit Pharma appoints founder Andrew Regan as CEO; Tapolczay transitions to licensing role

## Summary
- David Tapolczay resigned as CEO and board member effective April 12, 2025; to serve as Head of Licensing & Strategy at £240K salary.
- Andrew Regan appointed CEO effective April 15, 2025; continues as director and waives compensation except expense reimbursement.
- Faith Charles resigned from board effective April 16, 2025 for personal reasons; board reduced from seven to five members.
- Tapolczay to focus on out-licensing tapinarof patents; Regan highlights AI collaboration with Sarborg and 20-year patent strategy.

## SEC filing metadata
- accession: 0001641172-25-005036
- form_type: 8-K
- ticker: CDT
- cik: 0001896212
- company_name: CDT Equity Inc.
- filed_at: 2025-04-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1896212/000164117225005036/0001641172-25-005036-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1896212/000164117225005036/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-005036
- JSON: https://secwatch.observer/filing/0001641172-25-005036.json
- Plain text: https://secwatch.observer/filing/0001641172-25-005036.txt

## Source-grounded claims
- claim_id: 33eea3fca8
  claim: Andrew Regan was appointed as Chief Executive Officer at CDT Equity Inc..
  evidence_excerpt: On April 15, 2025, the Company appointed Andrew Regan as Chief Executive Officer, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1896212/000164117225005036/0001641172-25-005036-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.